179 related articles for article (PubMed ID: 1911189)
21. In vivo and in vitro studies of cyclophosphamide chemotherapy in a mouse mammary carcinoma by 31P NMR spectroscopy.
Street JC; Mahmood U; Matei C; Koutcher JA
NMR Biomed; 1995 Jun; 8(4):149-58. PubMed ID: 8771089
[TBL] [Abstract][Full Text] [Related]
22. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
[TBL] [Abstract][Full Text] [Related]
23. Effects of chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea on single-quantum- and triple-quantum-filtered 23Na and 31P nuclear magnetic resonance of the subcutaneously implanted 9L glioma.
Winter PM; Poptani H; Bansal N
Cancer Res; 2001 Mar; 61(5):2002-7. PubMed ID: 11280759
[TBL] [Abstract][Full Text] [Related]
24. 31P-Nuclear magnetic resonance spectroscopy of rat pituitary tumours in vivo.
Prysor-Jones RA; Silverlight JJ; Jenkins JS; Stevens AN; Rodrigues JL; Griffiths JR
J Endocrinol; 1985 Sep; 106(3):349-53. PubMed ID: 4045341
[TBL] [Abstract][Full Text] [Related]
25. A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism.
Smith TA; Glaholm J; Leach MO; Machin L; Collins DJ; Payne GS; McCready VR
Br J Cancer; 1991 Apr; 63(4):514-6. PubMed ID: 2021535
[TBL] [Abstract][Full Text] [Related]
26. Cross-resistance to tumour promoters in human cancer cell lines resistant to adriamycin or cisplatin.
Nishio K; Sugimoto Y; Nakagawa K; Niimi S; Fujiwara Y; Bungo M; Kasahara K; Fujiki H; Saijo N
Br J Cancer; 1990 Sep; 62(3):415-9. PubMed ID: 2206949
[TBL] [Abstract][Full Text] [Related]
27. [Experimental studies on evaluation of the effects of radiotherapy and chemotherapy in urogenital tumors using 31P-magnetic resonance spectroscopy].
Kanimoto Y; Suzuki Y; Okada K
Hinyokika Kiyo; 1994 Apr; 40(4):295-301. PubMed ID: 8191967
[TBL] [Abstract][Full Text] [Related]
28. Modulation of murine radiation-induced fibrosarcoma-1 tumor metabolism and blood flow in situ via glucose and mannitol administration monitored by 31P and 2H nuclear magnetic resonance spectroscopy.
Hwang YC; Kim SG; Evelhoch JL; Seyedsadr M; Ackerman JJ
Cancer Res; 1991 Jun; 51(12):3108-18. PubMed ID: 1904001
[TBL] [Abstract][Full Text] [Related]
29. [Comparison of stepwise and pulse induced cisplatin-resistant ovarian cancer cell sublines].
Cheng G; Li Y; Tian F
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):305-8. PubMed ID: 11783113
[TBL] [Abstract][Full Text] [Related]
30. [In vivo 31P magnetic resonance spectroscopy and MRI in patients with superficial tumors].
Vogl T; Peer F; Reiman V; Holtmann S; Rennschmid C; Weber H; Hahn D; Lissner J
Rofo; 1989 Jan; 150(1):58-65. PubMed ID: 2536498
[TBL] [Abstract][Full Text] [Related]
31. Effect of estrogen withdrawal on energy-rich phosphates and prediction of estrogen dependence monitored by in vivo 31P magnetic resonance spectroscopy of four human breast cancer xenografts.
Kristensen CA; Kristjansen PE; Brünner N; Clarke R; Spang-Thomsen M; Quistorff B
Cancer Res; 1995 Apr; 55(8):1664-9. PubMed ID: 7712472
[TBL] [Abstract][Full Text] [Related]
32. Pattern recognition of 31P magnetic resonance spectroscopy tumour spectra obtained in vivo.
Howells SL; Maxwell RJ; Howe FA; Peet AC; Stubbs M; Rodrigues LM; Robinson SP; Baluch S; Griffiths JR
NMR Biomed; 1993; 6(4):237-41. PubMed ID: 8217524
[TBL] [Abstract][Full Text] [Related]
33. Phosphorus metabolism during growth of lymphoma in mouse liver: a comparison of 31P magnetic resonance spectroscopy in vivo and in vitro.
Thomas CP; Dixon RM; Tian M; Butler SA; Counsell CJ; Bradley JK; Adams GE; Radda GK
Br J Cancer; 1994 Apr; 69(4):633-40. PubMed ID: 8142251
[TBL] [Abstract][Full Text] [Related]
34. The combined measurement of blood flow and metabolism in RIF-1 tumours in vivo. A study using H2 flow and 31P NMR spectroscopy.
Bhujwalla ZM; Tozer GM; Field SB; Proctor E; Busza A; Williams SR
NMR Biomed; 1990 Aug; 3(4):178-83. PubMed ID: 2206850
[TBL] [Abstract][Full Text] [Related]
35. 31P changes as a measure of therapy response in human osteosarcomas implanted into nude mice.
Kang H; Ballinger JR; Sweeney C; Croker BP; Scott KN
Magn Reson Imaging; 1994; 12(6):935-43. PubMed ID: 7968292
[TBL] [Abstract][Full Text] [Related]
36. The multidrug resistance phenotype: 31P nuclear magnetic resonance characterization and 2-deoxyglucose toxicity.
Kaplan O; Jaroszewski JW; Clarke R; Fairchild CR; Schoenlein P; Goldenberg S; Gottesman MM; Cohen JS
Cancer Res; 1991 Mar; 51(6):1638-44. PubMed ID: 1998955
[TBL] [Abstract][Full Text] [Related]
37. In vivo screening models of cisplatin-resistant human lung cancer cell lines using SCID mice.
Heike Y; Takahashi M; Ohira T; Arioka H; Funayama Y; Nishio K; Ogasawara H; Saijo N
Cancer Chemother Pharmacol; 1995; 35(3):200-4. PubMed ID: 7805177
[TBL] [Abstract][Full Text] [Related]
38. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
Meijer C; Mulder NH; Hospers GA; Uges DR; de Vries EG
Br J Cancer; 1990 Jul; 62(1):72-7. PubMed ID: 2390486
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP).
Nio Y; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
Anticancer Res; 1991; 11(2):761-7. PubMed ID: 2064331
[TBL] [Abstract][Full Text] [Related]
40. NMR spectroscopy analysis of phosphorus metabolites and the effect of adriamycin on these metabolite levels in an adriamycin-sensitive and -resistant human small cell lung carcinoma cell line.
de Jong S; Mulder NH; de Vries EG; Robillard GT
Br J Cancer; 1991 Feb; 63(2):205-12. PubMed ID: 1847646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
